|
|
|
|
|
|
|
Table 9. Estimated numbers of persons living with
HIV/AIDS, by race/ethnicity and transmission category, 2003�06�
areas with confidential name-based HIV infection reporting |
|
|
View PDF
|
|
|
|
|
|
|
Transmission category |
2003 |
2004 |
2005 |
2006 |
|
White |
Male adult or adolescent |
|
|
|
|
Male-to-male sexual contact |
92,985 |
97,844 |
102,890 |
108,306 |
Injection drug use |
11,552 |
11,766 |
11,955 |
12,332 |
Male-to-male sexual contact and injection drug use |
10,719 |
10,967 |
11,122 |
11,290 |
High-risk heterosexual contacta |
5,494 |
5,818 |
6,195 |
6,671 |
Otherb |
1,431 |
1,435 |
1,444 |
1,459 |
Subtotal |
122,180 |
127,830 |
133,606 |
140,057 |
Female adult or adolescent |
|
|
|
|
Injection drug use |
7,673 |
7,872 |
8,012 |
8,267 |
High-risk heterosexual contacta |
13,926 |
14,691 |
15,442 |
16,351 |
Otherb |
414 |
418 |
433 |
450 |
Subtotal |
22,014 |
22,981 |
23,887 |
25,068 |
Total adults and adolescents |
144,194 |
150,812 |
157,493 |
165,125 |
Child (<13 yrs) |
|
|
|
|
Perinatal |
796 |
795 |
799 |
801 |
Otherc |
169 |
167 |
164 |
154 |
Subtotal |
965 |
962 |
963 |
955 |
Total |
145,159 |
151,774 |
158,456 |
166,080 |
|
Black/African American |
Male adult or adolescent |
|
|
|
|
Male-to-male sexual contact |
57,262 |
61,182 |
65,449 |
70,324 |
Injection drug use |
30,880 |
31,067 |
31,049 |
31,369 |
Male-to-male sexual contact and injection drug use |
9,354 |
9,456 |
9,505 |
9,593 |
High-risk heterosexual contacta |
26,730 |
28,301 |
29,663 |
31,202 |
Otherb |
1,381 |
1,421 |
1,439 |
1,493 |
Subtotal |
125,608 |
131,427 |
137,106 |
143,981 |
Female adult or adolescent |
|
|
|
|
Injection drug use |
18,710 |
18,860 |
18,946 |
19,153 |
High-risk heterosexual contacta |
53,302 |
56,719 |
59,910 |
63,316 |
Otherb |
1,298 |
1,363 |
1,410 |
1,472 |
Subtotal |
73,310 |
76,942 |
80,266 |
83,940 |
Total adults and adolescents |
198,918 |
208,369 |
217,373 |
227,922 |
Child (<13 yrs) |
|
|
|
|
Perinatal |
4,036 |
4,057 |
4,086 |
4,071 |
Otherc |
280 |
285 |
280 |
285 |
Subtotal |
4,316 |
4,343 |
4,365 |
4,356 |
Total |
203,234 |
212,712 |
221,738 |
232,278 |
|
Hispanic/Latinod |
Male adult or adolescent |
|
|
|
|
Male-to-male sexual contact |
30,714 |
33,281 |
36,049 |
38,998 |
Injection drug use |
19,688 |
19,839 |
19,971 |
20,042 |
Male-to-male sexual contact and injection drug use |
4,376 |
4,469 |
4,546 |
4,631 |
High-risk heterosexual contacta |
9,033 |
9,682 |
10,398 |
11,198 |
Otherb |
388 |
410 |
431 |
457 |
Subtotal |
64,198 |
67,680 |
71,394 |
75,326 |
Female adult or adolescent |
|
|
|
|
Injection drug use |
6,938 |
6,998 |
7,008 |
7,055 |
High-risk heterosexual contacta |
14,908 |
15,829 |
16,830 |
17,874 |
Otherb |
308 |
327 |
351 |
382 |
Subtotal |
22,155 |
23,154 |
24,189 |
25,311 |
Total adults and adolescents |
86,354 |
90,834 |
95,583 |
100,637 |
Child (<13 yrs) |
|
|
|
|
Perinatal |
1,469 |
1,463 |
1,444 |
1,411 |
Otherc |
135 |
139 |
134 |
122 |
Subtotal |
1,604 |
1,601 |
1,578 |
1,534 |
Total |
87,958 |
92,436 |
97,161 |
102,171 |
|
Asian |
Male adult or adolescent |
|
|
|
|
Male-to-male sexual contact |
1,129 |
1,253 |
1,422 |
1,586 |
Injection drug use |
208 |
220 |
236 |
253 |
Male-to-male sexual contact and injection drug use |
67 |
76 |
79 |
86 |
High-risk heterosexual contacta |
284 |
313 |
347 |
379 |
Otherb |
31 |
30 |
31 |
31 |
Subtotal |
1,719 |
1,892 |
2,114 |
2,336 |
Female adult or adolescent |
|
|
|
|
Injection drug use |
72 |
81 |
92 |
99 |
High-risk heterosexual contacta |
387 |
446 |
496 |
548 |
Otherb |
21 |
23 |
25 |
27 |
Subtotal |
480 |
550 |
613 |
673 |
Total adults and adolescents |
2,199 |
2,442 |
2,727 |
3,009 |
Child (<13 yrs) |
|
|
|
|
Perinatal |
23 |
25 |
29 |
28 |
Otherc |
6 |
6 |
6 |
6 |
Subtotal |
29 |
31 |
35 |
34 |
Totale |
2,228 |
2,473 |
2,763 |
3,043 |
|
American Indian/Alaska Native |
Male adult or adolescent |
|
|
|
|
Male-to-male sexual contact |
769 |
816 |
870 |
939 |
Injection drug use |
195 |
202 |
219 |
216 |
Male-to-male sexual contact and injection drug use |
200 |
200 |
202 |
205 |
High-risk heterosexual contacta |
112 |
127 |
130 |
143 |
Otherb |
18 |
17 |
17 |
17 |
Subtotal |
1,294 |
1,362 |
1,438 |
1,520 |
Female adult or adolescent |
|
|
|
|
Injection drug use |
157 |
162 |
165 |
175 |
High-risk heterosexual contacta |
311 |
339 |
377 |
392 |
Otherb |
9 |
8 |
10 |
12 |
Subtotal |
477 |
509 |
552 |
578 |
Total adults and adolescents |
1,770 |
1,871 |
1,990 |
2,098 |
Child (<13 yrs) |
|
|
|
|
Perinatal |
17 |
18 |
18 |
20 |
Otherc |
1 |
1 |
1 |
1 |
Subtotal |
18 |
19 |
19 |
21 |
Total |
1,788 |
1,890 |
2,009 |
2,120 |
|
Native Hawaiian/Other Pacific Islander |
Male adult or adolescent |
|
|
|
|
Male-to-male sexual contact |
54 |
77 |
96 |
123 |
Injection drug use |
6 |
7 |
9 |
14 |
Male-to-male sexual contact and injection drug use |
3 |
4 |
5 |
6 |
High-risk heterosexual contacta |
7 |
8 |
14 |
18 |
Otherb |
0 |
0 |
0 |
1 |
Subtotal |
70 |
96 |
126 |
163 |
Female adult or adolescent |
|
|
|
|
Injection drug use |
3 |
5 |
6 |
8 |
High-risk heterosexual contacta |
9 |
19 |
25 |
35 |
Otherb |
0 |
0 |
0 |
0 |
Subtotal |
12 |
24 |
32 |
44 |
Total adults and adolescents |
82 |
120 |
158 |
206 |
Child (<13 yrs) |
|
|
|
|
Perinatal |
0 |
0 |
0 |
0 |
Otherc |
0 |
0 |
0 |
0 |
Subtotal |
0 |
0 |
0 |
0 |
Total |
82 |
120 |
158 |
206 |
Total casesf |
443,916 |
465,005 |
486,028 |
509,681 |
|
|
Note. These
numbers do not represent reported case counts. Rather, these
numbers are point estimates, which result from adjustments of
reported case counts. The reported case counts have been
adjusted for reporting delays and for redistribution of cases in
persons initially reported without an identified risk factor,
but not for incomplete reporting. |
Data include persons
with a diagnosis of HIV infection (not AIDS), a diagnosis of HIV
infection and a later diagnosis of AIDS, or concurrent diagnoses
of HIV infection and AIDS. |
See
Technical Notes for the
list of areas that have had laws or regulations requiring
confidential name-based HIV infection reporting since at least
2003. |
|
|
a |
Heterosexual contact with a person known to have, or to be at high risk for, HIV infection. |
b |
Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified. |
c |
Includes hemophilia, blood transfusion, and risk factor not reported or not identified. |
d |
Hispanics or Latinos can be of any race. |
e |
Includes Asian and Pacific Islander legacy cases (see
Technical Notes). |
f |
Includes persons of unknown race or multiple races and persons of unknown sex. Because column totals were calculated independently of the values for the subpopulations, the values in each column may not sum to the column total. |
|
Next: Table 10 |
|
|
|
|
|
|
|